- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05183633
A Pilot Study to Assess the Association Between Human Bioimpedance Measurements and Clinical Urodynamic Procedures
February 4, 2025 updated by: Curbell Medical Products, Inc.
A Pilot Study to Assess the Association between Human Bioimpedance Measurements and Clinical Urodynamic Procedures
Study Overview
Status
Terminated
Conditions
Detailed Description
The purpose of the study is to assess how well Curbell's Bladder Sensor device measuring bioimpedance correlates to urodynamic studies and the reported sensation subjects feel when reporting bladder fullness and their urge to urinate.
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Cheektowaga, New York, United States, 14225
- Western New York Urology Associates
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Patients that have been previously scheduled for a urodynamic study
Description
Inclusion Criteria:
- Patients that have been previously scheduled for a Urodynamic Study
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
One single trial
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation of Urge to Urinate to Bioimpedance. Our clinical trial is an attempt to determine the correlation of bioimpedance measurements versus bladder pressure (fullness) taken at the same time during a normally scheduled urodynamic study.
Time Frame: Bioimpedance measurements are taken in real time simultaneously with urodynamic pressure measurements. Therefore, the time frame is "zero." Each measurement characterizes actual bioimpedance at that point in time.
|
Our primary outcome is determining the correlation strength between the bladder's pressure measurements (acquired during a standard urodynamic study) and bioimpedance measurements.
That is, we are trying to find if bladder bioimpedance is correlated to bladder fullness, where pressure is the clinically-accepted measurement of bladder fullness in a urodynamic study.
|
Bioimpedance measurements are taken in real time simultaneously with urodynamic pressure measurements. Therefore, the time frame is "zero." Each measurement characterizes actual bioimpedance at that point in time.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2022
Primary Completion (Actual)
February 3, 2025
Study Completion (Actual)
February 3, 2025
Study Registration Dates
First Submitted
December 7, 2021
First Submitted That Met QC Criteria
January 5, 2022
First Posted (Actual)
January 10, 2022
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 4, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- HRP-503
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients Susceptible to Falls
-
Assistance Publique - Hôpitaux de ParisCompletedEnterobacteria Non Susceptible to Carbapenem Carrier | Enterobacteria Susceptible to Carbapenem CarrierFrance
-
Fondazione IRCCS Policlinico San Matteo di PaviaNot yet recruitingICU Patients With ECMO And-or RRT and With Gram Negative Infections Susceptible to BL-BLIsItaly
-
Fundación Pública Andaluza para la gestión de la...Not yet recruitingNeutropenia | Colonization | ESBL-producing Enterobacteriaceae Infections | Enterobacteria Non Susceptible to Carbapenem Carrier | Hemato-oncologic PatientsSpain
-
King Abdulaziz UniversityNot yet recruitingSound Newly Erupted First Permanent Molars With Deep Fissures Susceptible to Caries
-
Helse Møre og Romsdal HFNorwegian University of Science and Technology; Sykehuset Innlandet HFCompletedAccidental Falls | Hospitalized PatientsNorway
-
University Hospital, AngersCompletedto Elaborate a New Simple Clinical Tool for the Risk of Falls Among Older Inpatients.France
-
Centre Hospitalier Universitaire, AmiensCompletedBacterial Infection With One or More Extended Spectrum Betalactamases Remaining Susceptible to TemocillinFrance
-
Capital Medical UniversityNot yet recruiting
-
AstraZenecaWithdrawnSelf-administered Questionnaire to Patients
-
Hospital Ernesto DornellesFederal University of Rio Grande do Sul; Hospital Moinhos de VentoUnknownDifficult-to-wean Adult PatientsBrazil